Sushila Dalal

3.3k total citations
90 papers, 2.2k citations indexed

About

Sushila Dalal is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Sushila Dalal has authored 90 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Genetics, 59 papers in Epidemiology and 34 papers in Surgery. Recurrent topics in Sushila Dalal's work include Inflammatory Bowel Disease (67 papers), Microscopic Colitis (42 papers) and Autoimmune and Inflammatory Disorders (20 papers). Sushila Dalal is often cited by papers focused on Inflammatory Bowel Disease (67 papers), Microscopic Colitis (42 papers) and Autoimmune and Inflammatory Disorders (20 papers). Sushila Dalal collaborates with scholars based in United States, Japan and Israel. Sushila Dalal's co-authors include Eugene B. Chang, John H. Kwon, David T. Rubin, Russell D. Cohen, Atsushi Sakuraba, Joel Pekow, Bruce E. Kemp, Lee A. Witters, Kenta Hara and Chiharu Tokunaga and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Gastroenterology.

In The Last Decade

Sushila Dalal

80 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sushila Dalal United States	24	941	911	870	636	285	90	2.2k
Eleonora A. Festen Netherlands	23	1.0k 1.1×	1.1k 1.2×	592 0.7×	574 0.9×	517 1.8×	70	2.4k
Rui Feng China	24	687 0.7×	613 0.7×	377 0.4×	437 0.7×	263 0.9×	80	1.8k
Martina E. Spehlmann Germany	18	1.1k 1.2×	987 1.1×	623 0.7×	374 0.6×	699 2.5×	45	2.5k
Kristen O. Arseneau United States	26	723 0.8×	789 0.9×	556 0.6×	545 0.9×	589 2.1×	36	2.3k
Hongjie Zhang China	27	905 1.0×	597 0.7×	402 0.5×	565 0.9×	430 1.5×	87	2.2k
Philip Allan United Kingdom	12	726 0.8×	692 0.8×	595 0.7×	344 0.5×	915 3.2×	34	2.1k
Maneesh Dave United States	20	469 0.5×	651 0.7×	672 0.8×	729 1.1×	288 1.0×	45	1.9k
Lisa S. Poritz United States	26	549 0.6×	706 0.8×	506 0.6×	899 1.4×	302 1.1×	68	2.2k
Mike G. Laukoetter Germany	20	855 0.9×	500 0.5×	257 0.3×	825 1.3×	454 1.6×	30	2.3k
Balfour R. Sartor United States	19	914 1.0×	384 0.4×	356 0.4×	242 0.4×	316 1.1×	32	1.7k

Countries citing papers authored by Sushila Dalal

Since Specialization

Citations

This map shows the geographic impact of Sushila Dalal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sushila Dalal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sushila Dalal more than expected).

Fields of papers citing papers by Sushila Dalal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sushila Dalal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sushila Dalal. The network helps show where Sushila Dalal may publish in the future.

Co-authorship network of co-authors of Sushila Dalal

This figure shows the co-authorship network connecting the top 25 collaborators of Sushila Dalal. A scholar is included among the top collaborators of Sushila Dalal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sushila Dalal. Sushila Dalal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Yu, Bingqing Xie, Cambrian Y. Liu, et al.. (2025). Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patients. Nature Communications. 16(1). 904–904. 1 indexed citations

Lombard, R, Shintaro Akiyama, Nathaniel A. Cohen, et al.. (2024). Extensive Disease and Exposure to Multiple Biologics Precolectomy Is Associated with Endoscopic Cuffitis Post–Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis. Inflammatory Bowel Diseases. 31(1). 72–76. 1 indexed citations

Cleveland, Noa Krugliak, Jeremy A. Klein, Nicole Garcia, et al.. (2024). Mo1848 UPADACITINIB IS EFFECTIVE AND SAFE FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE: 1-YEAR PROSPECTIVE REAL-WORLD EXPERIENCE. Gastroenterology. 166(5). S–1141. 1 indexed citations

Choi, D, Elise Fear, Russell D. Cohen, et al.. (2024). P848 Risankizumab Effectiveness in Ustekinumab-naïve and Ustekinumab-experienced Patients with Crohn’s Disease- Real-world Data from a Large Tertiary Center. Journal of Crohn s and Colitis. 18(Supplement_1). i1565–i1565. 1 indexed citations

Mullowney, Michael W., Aretha Fiebig, Matthew K. Schnizlein, et al.. (2024). Microbially catalyzed conjugation of GABA and tyramine to bile acids. Journal of Bacteriology. 206(1). e0042623–e0042623. 6 indexed citations

Cleveland, Noa Krugliak, D Choi, Nicole Garcia, et al.. (2023). P724 Upadacitinib is Effective and Safe in Tofacitinib-Experienced Patients with Ulcerative Colitis: A Prospective Real-World Experience. Journal of Crohn s and Colitis. 17(Supplement_1). i854–i856. 4 indexed citations

Fiebig, Aretha, Matthew K. Schnizlein, Florian Trigodet, et al.. (2023). Bile acid fitness determinants of a Bacteroides fragilis isolate from a human pouchitis patient. mBio. 15(1). e0283023–e0283023. 6 indexed citations

Zinger, Adar, David Choi, Nicole Garcia, et al.. (2023). S1094 Effectiveness and Safety of Risankizumab Induction Therapy in Crohn’s Disease: Prospective Real-World Experience in a Large Tertiary Center. The American Journal of Gastroenterology. 118(10S). S834–S834. 1 indexed citations

Choi, D, Nicole Garcia, Nathaniel A. Cohen, et al.. (2023). P580 Upadacitinib is effective and safe for Ulcerative Colitis: prospective real-world experience. Journal of Crohn s and Colitis. 17(Supplement_1). i707–i709.

10.

Cohen, Nathaniel A., Namrata Setia, Michael J. Anderson, et al.. (2022). Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis. Digestive Diseases and Sciences. 68(3). 897–901. 1 indexed citations

11.

Buisson, Anthony, Lisa Cannon, Konstantin Umanskiy, et al.. (2021). Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease. Intestinal Research. 20(3). 303–312. 10 indexed citations

12.

Cohen, Nathaniel A., Cindy Traboulsi, Shruti Patel, et al.. (2021). P455 Tofacitinib Therapy is Effective for Arthralgias Associated with Active Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 15(Supplement_1). S450–S450. 1 indexed citations

13.

Ollech, Jacob E., Noam Peleg, Jingzhou Wang, et al.. (2020). Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 19(1). 104–110. 65 indexed citations

14.

Patel, Parita, Guimin Gao, Sushila Dalal, et al.. (2020). Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 27(2). 236–241. 22 indexed citations

15.

Wang, Jingzhou, Wenfei Wang, Atsushi Sakuraba, et al.. (2020). Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 51(12). 1365–1372. 6 indexed citations

16.

Weisshof, Roni, Jacob E. Ollech, Katia El Jurdi, et al.. (2019). Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe. Journal of Crohn s and Colitis. 13(9). 1105–1110. 25 indexed citations

17.

Christensen, Britt, Katia El Jurdi, Victoria Rai, et al.. (2019). Follow-Up of Patients With Ulcerative Colitis and Histological Normalization. Clinical Gastroenterology and Hepatology. 18(4). 987–988.e1. 4 indexed citations

18.

Huang, Yong, Sushila Dalal, Dionysios A. Antonopoulos, et al.. (2017). Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis. Inflammatory Bowel Diseases. 23(3). 1–1. 19 indexed citations

19.

Ward, Marc A., Joseph F. Pierre, Raquel Franco Leal, et al.. (2016). Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility. American Journal of Physiology-Gastrointestinal and Liver Physiology. 310(11). G973–G988. 23 indexed citations

20.

Dalal, Sushila & Russell D. Cohen. (2015). What to Do When Biologic Agents Are Not Working in Inflammatory Bowel Disease Patients.. PubMed. 11(10). 657–65. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact